10 Stocks Under $10 with High Potential

3. Nuvation Bio Inc. (NYSE:NUVB)

Price: $6.55

Upside Potential: 60.31%

Number of Hedge Fund Holders: 39

Nuvation Bio Inc. (NYSE:NUVB) is one of the Stocks to Buy Under $10 with High Potential. On January 15, Soumit Roy from JonesTrading reiterated a Buy rating on the stock and raised the price target from $10 to $12. Earlier, on January 13, Gregory Renza from Truist Financial also reiterated a Buy rating on Nuvation Bio Inc. (NYSE:NUVB) without disclosing any price targets.

Analyst Roy from JonesTrading noted that his bullish sentiment is based on the upcoming data from a study of Safusidenib. It is an IDH1 inhibitor for patients who have undergone surgery. Roy expects data from the study by the end of the year. The analyst noted that he has increased the success probability of Safusidenib from 30% to 50%. He also expects accelerated approval with launch now anticipated in 2029 rather than 2030.

That said, on January 13, H.C. Wainwright lowered the price target on the stock from $18 to $17, while maintaining a Buy rating on the stock. The firm highlighted that the reduced price target is due to IBTROZI’s fiscal Q4 2025 sales of $15.7 million, which will be below the firm’s expectations of $16.4 million. However, the sales figure was still in line with the general consensus of $15.5 million.  As a result, the firm lowered its 2026 sales target to $163.2 million from $169.6 million.

Nuvation Bio Inc. (NYSE:NUVB) is a biopharmaceutical company focused on the development of novel oncology therapies.